BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21920822)

  • 1. Anti-FcεR1 antibody injections activate basophils and mast cells and delay Type 1 diabetes onset in NOD mice.
    Hübner MP; Larson D; Torrero MN; Mueller E; Shi Y; Killoran KE; Mitre E
    Clin Immunol; 2011 Nov; 141(2):205-17. PubMed ID: 21920822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FcepsilonRI-alpha siRNA inhibits the antigen-induced activation of mast cells.
    Safaralizadeh R; Soheili ZS; Deezagi A; Pourpak Z; Samiei S; Moin M
    Iran J Allergy Asthma Immunol; 2009 Dec; 8(4):177-83. PubMed ID: 20404387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bispecific antibody against human IgE and human FcgammaRII that inhibits antigen-induced histamine release by human mast cells and basophils.
    Tam SW; Demissie S; Thomas D; Daëron M
    Allergy; 2004 Jul; 59(7):772-80. PubMed ID: 15180766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helminth protection against autoimmune diabetes in nonobese diabetic mice is independent of a type 2 immune shift and requires TGF-β.
    Hübner MP; Shi Y; Torrero MN; Mueller E; Larson D; Soloviova K; Gondorf F; Hoerauf A; Killoran KE; Stocker JT; Davies SJ; Tarbell KV; Mitre E
    J Immunol; 2012 Jan; 188(2):559-68. PubMed ID: 22174447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential engagement of FcεRI on Mast Cells and Basophil Histamine H(4) Receptor and FcεRI in Allergic Rhinitis.
    Shiraishi Y; Jia Y; Domenico J; Joetham A; Karasuyama H; Takeda K; Gelfand EW
    J Immunol; 2013 Jan; 190(2):539-48. PubMed ID: 23241885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential modulation of mediator release from human basophils and mast cells by mizolastine.
    Triggiani M; Giannattasio G; Balestrieri B; Granata F; Gelb MH; de Paulis A; Marone G
    Clin Exp Allergy; 2004 Feb; 34(2):241-9. PubMed ID: 14987304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine releasing cells of the newborn. Mast cells from the umbilical cord matrix and basophils from cord blood.
    Damsgaard TE; Nielsen BW; Henriques U; Hansen B; Herlin T; Schiøtz PO
    Pediatr Allergy Immunol; 1996 May; 7(2):83-90. PubMed ID: 8902858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils.
    Song Y; Qu C; Srivastava K; Yang N; Busse P; Zhao W; Li XM
    J Allergy Clin Immunol; 2010 Dec; 126(6):1208-17.e3. PubMed ID: 21134573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine releasability of basophils and skin mast cells in chronic urticaria.
    Zuberbier T; Schwarz S; Hartmann K; Pfrommer C; Czarnetzki BM
    Allergy; 1996 Jan; 51(1):24-8. PubMed ID: 8721524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and basophils are selectively activated in vitro and in vivo through CD200R3 in an IgE-independent manner.
    Kojima T; Obata K; Mukai K; Sato S; Takai T; Minegishi Y; Karasuyama H
    J Immunol; 2007 Nov; 179(10):7093-100. PubMed ID: 17982101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basophil-mast cell response syndromes: a unified clinical approach.
    Patterson R; Pruzansky JJ; Dykewicz MS; Lawrence ID
    Allergy Proc; 1988; 9(6):611-20. PubMed ID: 3066689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal mast cell activation by autoantibodies against the high affinity IgE receptor in chronic urticaria.
    Niimi N; Francis DM; Kermani F; O'Donnell BF; Hide M; Kobza-Black A; Winkelmann RK; Greaves MW; Barr RM
    J Invest Dermatol; 1996 May; 106(5):1001-6. PubMed ID: 8618029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Streptococcal H2O2 inhibits IgE-triggered degranulation of RBL-2H3 mast cell/basophil cell line by inducing cell death.
    Okahashi N; Nakata M; Hirose Y; Morisaki H; Kataoka H; Kuwata H; Kawabata S
    PLoS One; 2020; 15(4):e0231101. PubMed ID: 32302339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE.
    Patella V; Giuliano A; Bouvet JP; Marone G
    J Immunol; 1998 Nov; 161(10):5647-55. PubMed ID: 9820545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-purification of the immunoglobulin E-sweat antigen acting on mast cells and basophils in atopic dermatitis.
    Tanaka A; Tanaka T; Suzuki H; Ishii K; Kameyoshi Y; Hide M
    Exp Dermatol; 2006 Apr; 15(4):283-90. PubMed ID: 16512875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of chronic urticaria.
    Kaplan AP; Greaves M
    Clin Exp Allergy; 2009 Jun; 39(6):777-87. PubMed ID: 19400905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-3 but not monomeric IgE regulates FcεRI levels and cell survival in primary human basophils.
    Zellweger F; Buschor P; Hobi G; Brigger D; Dahinden CA; Villiger PM; Eggel A
    Cell Death Dis; 2018 May; 9(5):510. PubMed ID: 29724998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation.
    Zhu D; Kepley CL; Zhang M; Zhang K; Saxon A
    Nat Med; 2002 May; 8(5):518-21. PubMed ID: 11984598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basophil responsiveness in chronic urticaria.
    Saini SS
    Curr Allergy Asthma Rep; 2009 Jul; 9(4):286-90. PubMed ID: 19656475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen-induced reduction in mast cell and basophil functional responses due to reduced Syk protein levels.
    Kepley CL
    Int Arch Allergy Immunol; 2005 Sep; 138(1):29-39. PubMed ID: 16088210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.